NIOX Group PLC

LSE:NIOX UK Medical Devices
Market Cap
$3.00 Million
GBX24.66 Billion GBX
Market Cap Rank
#43082 Global
#698 in UK
Share Price
GBX59.00
Change (1 day)
-4.84%
52-Week Range
GBX54.60 - GBX76.00
All Time High
GBX306.79
Categories
Companies in UK Medical Devices
About

NIOX Group Plc engages in the design, development, and commercialization of medical devices for asthma diagnosis, monitoring, and management worldwide. It offers NIOX VERO, a non-invasive and point-of-care system that comprises a small portable device and a range of consumables, including sensors, individual disposable mouthpieces, and breathing handles for the measurement of Fractional Exhaled N… Read more

NIOX Group PLC (NIOX) - Net Assets

Latest net assets as of June 2025: GBX64.40 Million GBX

Based on the latest financial reports, NIOX Group PLC (NIOX) has net assets worth GBX64.40 Million GBX as of June 2025.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (GBX71.00 Million) and total liabilities (GBX6.60 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets GBX64.40 Million
% of Total Assets 90.7%
Annual Growth Rate 6.41%
5-Year Change -27.35%
10-Year Change -29.83%
Growth Volatility 116.65

NIOX Group PLC - Net Assets Trend (2013–2024)

This chart illustrates how NIOX Group PLC's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for NIOX Group PLC (2013–2024)

The table below shows the annual net assets of NIOX Group PLC from 2013 to 2024.

Year Net Assets Change
2024-12-31 GBX59.50 Million -29.00%
2023-12-31 GBX83.80 Million 0.00%
2023-12-30 GBX83.80 Million +2.32%
2022-12-31 GBX81.90 Million 0.00%
2022-12-30 GBX81.90 Million +22.60%
2021-12-31 GBX66.80 Million 0.00%
2021-12-30 GBX66.80 Million +1.06%
2020-12-31 GBX66.10 Million 0.00%
2020-12-30 GBX66.10 Million -22.05%
2019-12-31 GBX84.80 Million 0.00%
2019-12-30 GBX84.80 Million -53.66%
2018-12-31 GBX183.00 Million 0.00%
2018-12-30 GBX183.00 Million -50.75%
2017-12-31 GBX371.60 Million 0.00%
2017-12-30 GBX371.60 Million +18.87%
2016-12-31 GBX312.60 Million 0.00%
2016-12-30 GBX312.60 Million -29.10%
2015-12-31 GBX440.90 Million 0.00%
2015-12-30 GBX440.90 Million +131.08%
2014-12-31 GBX190.80 Million 0.00%
2014-12-30 GBX190.80 Million +535.05%
2013-12-31 GBX30.05 Million 0.00%
2013-12-30 GBX30.05 Million --

Equity Component Analysis

This analysis shows how different components contribute to NIOX Group PLC's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 11687900000.0% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Retained Earnings GBX43.40 Million 72.94%
Common Stock GBX300.00K 0.50%
Other Comprehensive Income GBX15.60 Million 26.22%
Other Components GBX200.00K 0.34%
Total Equity GBX59.50 Million 100.00%

NIOX Group PLC Competitors by Market Cap

The table below lists competitors of NIOX Group PLC ranked by their market capitalization.

Company Market Cap
Caspian Services Inc
PINK:CSSV
 		$31.59K
CHINA LIFE INS -H-
HM:CHL
 		$31.61K
Beximco Pharmaceuticals Limited
LSE:BXP
 		$31.61K
IUS
WAR:IUS
 		$31.63K
KLBN11F
SA:KLBN11F
 		$31.48K
PLAYTECH
BE:PL8
 		$31.46K
VSFFF
OTCGREY:VSFFF
 		$31.46K
Media Lab SpA
PA:MLLAB
 		$31.45K

Equity Growth Attribution

This analysis shows how different factors contributed to changes in NIOX Group PLC's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 83,800,000 to 59,500,000, a change of -24,300,000 (-29.0%).
  • Net income of 3,700,000 contributed positively to equity growth.
  • Dividend payments of 4,200,000 reduced retained earnings.
  • Share repurchases of 21,300,000 reduced equity.
  • New share issuances of 100,000 increased equity.
  • Other comprehensive income decreased equity by 2,600,000.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income GBX3.70 Million +6.22%
Dividends Paid GBX4.20 Million -7.06%
Share Repurchases GBX21.30 Million -35.8%
Share Issuances GBX100.00K +0.17%
Other Comprehensive Income GBX-2.60 Million -4.37%
Total Change GBX- -29.00%

Book Value vs Market Value Analysis

This analysis compares NIOX Group PLC's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 444.44x
  • The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
  • The price-to-book ratio has increased from 368.04x to 444.44x over the analyzed period, suggesting growing market confidence.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2013-12-30 GBX0.16 GBX59.00 x
2013-12-31 GBX0.16 GBX59.00 x
2014-12-30 GBX1.13 GBX59.00 x
2014-12-31 GBX1.13 GBX59.00 x
2015-12-30 GBX1.64 GBX59.00 x
2015-12-31 GBX1.64 GBX59.00 x
2016-12-30 GBX0.99 GBX59.00 x
2016-12-31 GBX0.99 GBX59.00 x
2017-12-30 GBX0.70 GBX59.00 x
2017-12-31 GBX0.70 GBX59.00 x
2018-12-30 GBX0.37 GBX59.00 x
2018-12-31 GBX0.37 GBX59.00 x
2019-12-30 GBX0.23 GBX59.00 x
2019-12-31 GBX0.23 GBX59.00 x
2020-12-30 GBX0.17 GBX59.00 x
2020-12-31 GBX0.17 GBX59.00 x
2021-12-30 GBX0.15 GBX59.00 x
2021-12-31 GBX0.15 GBX59.00 x
2022-12-30 GBX0.18 GBX59.00 x
2022-12-31 GBX0.18 GBX59.00 x
2023-12-30 GBX0.19 GBX59.00 x
2023-12-31 GBX0.19 GBX59.00 x
2024-12-31 GBX0.13 GBX59.00 x

Capital Efficiency Dashboard

This dashboard shows how efficiently NIOX Group PLC utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 6.22%
  • The company has moderate efficiency in generating returns from equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 8.85%
  • • Asset Turnover: 0.61x
  • • Equity Multiplier: 1.15x
  • Recent ROE (6.22%) is above the historical average (-30.42%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2013 -66.50% 0.00% 0.00x 1.27x GBX-22.99 Million
2013 -66.50% 0.00% 0.00x 1.27x GBX-22.99 Million
2014 -18.40% 0.00% 0.00x 1.05x GBX-54.18 Million
2014 -18.40% 0.00% 0.00x 1.05x GBX-54.18 Million
2015 -12.22% -462.04% 0.02x 1.20x GBX-90.75 Million
2015 -12.22% -462.04% 0.02x 1.20x GBX-90.75 Million
2016 -48.91% -594.37% 0.07x 1.19x GBX-165.37 Million
2016 -48.91% -594.37% 0.07x 1.19x GBX-165.37 Million
2017 -44.08% -214.04% 0.12x 1.79x GBX-121.58 Million
2017 -44.08% -214.04% 0.12x 1.79x GBX-121.58 Million
2018 -93.01% -242.44% 0.16x 2.44x GBX-129.69 Million
2018 -93.01% -242.44% 0.16x 2.44x GBX-129.69 Million
2019 -56.96% -139.60% 0.14x 2.91x GBX-56.78 Million
2019 -56.96% -139.60% 0.14x 2.91x GBX-56.78 Million
2020 -50.68% -140.17% 0.23x 1.56x GBX-40.11 Million
2020 -50.68% -140.17% 0.23x 1.56x GBX-40.11 Million
2021 5.39% 12.90% 0.32x 1.29x GBX-3.08 Million
2021 5.39% 12.90% 0.32x 1.29x GBX-3.08 Million
2022 19.66% 51.44% 0.32x 1.20x GBX7.91 Million
2022 19.66% 51.44% 0.32x 1.20x GBX7.91 Million
2023 12.77% 29.08% 0.40x 1.09x GBX2.32 Million
2023 12.77% 29.08% 0.40x 1.09x GBX2.32 Million
2024 6.22% 8.85% 0.61x 1.15x GBX-2.25 Million

Industry Comparison

This section compares NIOX Group PLC's net assets metrics with peer companies in the Medical Devices industry.

Industry Context

  • Industry: Medical Devices
  • Average net assets among peers: $16,329,336
  • Average return on equity (ROE) among peers: -33.60%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
NIOX Group PLC (NIOX) GBX64.40 Million -66.50% 0.10x $31.53K
AOTI Inc (AOTI) $3.41 Million 51.02% 1.74x $5.95K
Belluscura Plc (BELL) $1.20 Million -81.38% 0.34x $366.21
Creo Medical Group PLC (CREO) $59.80 Million -36.29% 0.28x $8.34K
Inspiration Healthcare Group PLC (IHC) $28.97 Million -20.83% 0.69x $2.87K
Intelligent Ultrasound Group PLC (IUG) $12.16 Million -24.53% 0.32x $5.19K
Rua Life Sciences PLC (RUA) $7.39 Million 0.01% 0.25x $1.01K
Surgical Innovations Group plc (SUN) $1.37 Million -123.23% 1.08x $510.74